At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Restylane Perlane +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Multi-center, Evaluator-blinded Study in China to Evaluate the Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds
In Brief
A clinical study evaluating Restylane Perlane and Restylane for Nasolabial Folds in Chinese Population. Completed, enrolled 100 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine the safety and efficacy of using Restylane Perlane compared to Restylane for correction of moderate to severe nasolabial folds (NLF) in a Chinese population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNasolabial Folds in Chinese Population
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartMay 2015
First PostedMay 2015
Primary CompletionMar 2016
Study CompletionAug 2016
TodayJul 2026
First PostedMay 4, 2015
Enrollment StartMay 1, 2015
Primary CompletionMar 1, 2016
Study CompletionAug 1, 2016
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 11.2 years ago
Interventions
Restylane Perlanedevice
Intradermal injection
Restylanedevice
Intradermal injection